LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.97 | 27.76 | 3454 | 6656 | 0.5189 | 0.8407 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.97 | 27.76 | 2025 | 6656 | 0.3042 | 0.7205 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.97 | 27.76 | 2606 | 6656 | 0.3915 | 0.7763 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.97 | 27.76 | 580 | 6656 | 0.0871 | 0.4688 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.97 | 27.76 | 4149 | 6656 | 0.6233 | 0.8839 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.67 | 27.76 | 313 | 6695 | 0.0467 | 0.3581 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.67 | 27.76 | 3593 | 6695 | 0.5366 | 0.8487 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.67 | 27.76 | 2205 | 6695 | 0.3293 | 0.7381 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.67 | 27.76 | 2784 | 6695 | 0.4158 | 0.7901 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.67 | 27.76 | 631 | 6695 | 0.0942 | 0.4840 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.67 | 27.76 | 4377 | 6695 | 0.6537 | 0.8954 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.37 | 27.76 | 356 | 6879 | 0.0518 | 0.3782 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.37 | 27.76 | 3725 | 6879 | 0.5415 | 0.8515 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.37 | 27.76 | 2201 | 6879 | 0.3200 | 0.7330 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.37 | 27.76 | 2843 | 6879 | 0.4133 | 0.7897 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.37 | 27.76 | 668 | 6879 | 0.0971 | 0.4917 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.37 | 27.76 | 4484 | 6879 | 0.6518 | 0.8952 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.08 | 27.76 | 345 | 6849 | 0.0504 | 0.3731 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.08 | 27.76 | 3812 | 6849 | 0.5565 | 0.8578 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.08 | 27.76 | 2095 | 6849 | 0.3059 | 0.7230 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.08 | 27.76 | 2902 | 6849 | 0.4237 | 0.7951 | MN20160318_Q01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.08 | 27.76 | 640 | 6849 | 0.0934 | 0.4842 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.08 | 27.76 | 4603 | 6849 | 0.6720 | 0.9024 | MN20160318_Q01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.78 | 27.76 | 308 | 6893 | 0.0447 | 0.3532 | MN20160318_Q01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.78 | 27.76 | 3829 | 6893 | 0.5555 | 0.8575 | MN20160318_Q01 | E20 |